Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Placebo-Controlled Preliminary Study of the Efficacy, Safety and Tolerability of ST101 Tablets in the Treatment of Alzheimer's Disease in Subjects Concurrently Receiving Donepezil (Aricept®)

NCT00842816 is registered in ClinicalTrials.gov with Sonexa Therapeutics, Inc. as lead sponsor.

NCT NCT00842816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00842816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Placebo-Controlled Preliminary Study of the Efficacy, Safety and Tolerability of ST101 Tablets in the Treatment of Alzheimer's Disease in Subjects Concurrently Receiving Donepezil (Aricept®)
Lead sponsor
Sonexa Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
May 31, 2011
Enrollment
210 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease